186 related articles for article (PubMed ID: 24807157)
1. Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.
Pass HI; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP; Rusch VW;
J Thorac Oncol; 2014 Jun; 9(6):856-64. PubMed ID: 24807157
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
[TBL] [Abstract][Full Text] [Related]
3. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
Gill RR; Richards WG; Yeap BY; Matsuoka S; Wolf AS; Gerbaudo VH; Bueno R; Sugarbaker DJ; Hatabu H
AJR Am J Roentgenol; 2012 Feb; 198(2):359-63. PubMed ID: 22268178
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
5. Initial analysis of the international association for the study of lung cancer mesothelioma database.
Rusch VW; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Pass H; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP;
J Thorac Oncol; 2012 Nov; 7(11):1631-9. PubMed ID: 23070243
[TBL] [Abstract][Full Text] [Related]
6. The importance of surgical staging in the treatment of malignant pleural mesothelioma.
Rusch VW; Venkatraman E
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):815-25; discussion 825-6. PubMed ID: 8614142
[TBL] [Abstract][Full Text] [Related]
7. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
[TBL] [Abstract][Full Text] [Related]
8. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
Flores RM; Zakowski M; Venkatraman E; Krug L; Rosenzweig K; Dycoco J; Lee C; Yeoh C; Bains M; Rusch V
J Thorac Oncol; 2007 Oct; 2(10):957-65. PubMed ID: 17909360
[TBL] [Abstract][Full Text] [Related]
10. Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.
Kao SC; Vardy J; Chatfield M; Corte P; Pavlakis N; Clarke C; van Zandwijk N; Clarke S
Clin Lung Cancer; 2013 Jan; 14(1):70-7. PubMed ID: 22658812
[TBL] [Abstract][Full Text] [Related]
11. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
[TBL] [Abstract][Full Text] [Related]
12. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.
Baud M; Strano S; Dechartres A; Jouni R; Triponez F; Chouaid C; Forgez P; Damotte D; Roche N; Régnard JF; Alifano M
J Thorac Cardiovasc Surg; 2013 May; 145(5):1305-11. PubMed ID: 23072703
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma.
Berardi R; Fiordoliva I; De Lisa M; Ballatore Z; Caramanti M; Morgese F; Savini A; Rinaldi S; Torniai M; Tiberi M; Ferrini C; Onofri A; Cascinu S
Tumori; 2016; 102(2):190-5. PubMed ID: 26893272
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting survival in malignant pleural mesothelioma: analysis of 125 subjects.
Komurcuoglu B; Cirak AK; Kirakli SC; Polat G; Yucel N; Usluer O; Erer O; Balci G; Gayaf M; Guldaval F; Aktogu S; Guclu S; Ozsoz A; Halilcolar H
Tumori; 2014; 100(1):55-9. PubMed ID: 24675492
[TBL] [Abstract][Full Text] [Related]
15. The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma.
Wolf AS; Rosenthal A; Giroux DJ; Nowak AK; Bille A; de Perrot M; Kindler HL; Rice D; Opitz I; Rusch VW; Pass HI; ;
J Thorac Oncol; 2023 Dec; 18(12):1689-1702. PubMed ID: 37567386
[TBL] [Abstract][Full Text] [Related]
16. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.
Rusch VW; Venkatraman ES
Ann Thorac Surg; 1999 Nov; 68(5):1799-804. PubMed ID: 10585061
[TBL] [Abstract][Full Text] [Related]
17. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
Sugarbaker DJ; Flores RM; Jaklitsch MT; Richards WG; Strauss GM; Corson JM; DeCamp MM; Swanson SJ; Bueno R; Lukanich JM; Baldini EH; Mentzer SJ
J Thorac Cardiovasc Surg; 1999 Jan; 117(1):54-63; discussion 63-5. PubMed ID: 9869758
[TBL] [Abstract][Full Text] [Related]
18. Stratification of malignant pleural mesothelioma prognosis using recursive partitioning analysis.
Suzuki H; Asami K; Hirashima T; Okamoto N; Yamadori T; Tamiya M; Morishita N; Shiroyama T; Takeoka S; Osa A; Azuma Y; Okishio K; Kawaguchi T; Atagi S; Kawase I
Lung; 2014 Feb; 192(1):191-5. PubMed ID: 24141556
[TBL] [Abstract][Full Text] [Related]
19. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
20. Poor Prognostic Factors in Patients with Malignant Pleural Mesothelioma Classified as Pathological Stage IB According to the Eighth Edition TNM Classification.
Takuwa T; Hashimoto M; Kuroda A; Nakamura A; Nakamichi T; Fukuda A; Matsumoto S; Kondo N; Hasegawa S
Ann Surg Oncol; 2018 Jun; 25(6):1572-1579. PubMed ID: 29616420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
